RTC-30
RTC-30 is an optimized phenothiazine with anti-cancer potency. RTC-30 contains a hydroxylated linker (N) that confers increased oral bioavailability[1].
Product Specifications
CAS Number
1423077-95-5
UNSPSC
12352005
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rtc-30.html
Concentration
10mM
Purity
99.13
Solubility
DMSO : 15 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(OC(F)(F)F)C=C1)(NC[C@H](O)CN2C3=CC=CC=C3CCC4=CC=CC=C42)=O
Molecular Formula
C24H23F3N2O4S
Molecular Weight
492.51
References & Citations
[1]Kastrinsky DB, et al. Reengineered tricyclic anti-cancer agents. Bioorg Med Chem. 2015 Oct 1;23 (19) :6528-34.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A133872 100 µL
Anti-F/Fusion glycoprotein F0 (Recombinant , Monoclonal, VHH)
Sign In for Pricing
View Details 